Recruiting Clinical Trials

Displaying 31 - 40 of 242 result(s)
Study Title Condition Phase Location
A Phase II Multi-center, Single Arm, Safety and Efficacy Study of MBG453 in Combination With Azacitidine and Venetoclax for the Treatment of Acute Myeloid Leukemia (AML) in Adult Patients Unfit for Chemotherapy Acute Myeloid Leukemia Phase 2
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Canada
  • Country: 
A Randomized, Sham-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Intrathecal OAV101 in Patients Type 2 Spinal Muscular Atrophy (SMA) Who Are ≥ 2 to < 18 Years of Age, Treatment Naive, Sitting, and Never Ambulatory Type 2 Spinal Muscular Atrophy Phase 3
  • Country: 
    United States
  • Country: 
    Singapore
  • Country: 
    South Africa
  • Country: 
A Randomized, Open-label, Multi-center, Phase II Study of Asciminib Versus Best Available Therapy in Chinese Patients With Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated With 2 or More Tyrosine Kinase Inhibitors Leukemia, Chronic Myelogenous Phase 2
  • Country: 
    China
An Open-label, Multi-center, Phase 2 Basket Study to Assess Efficacy, Safety and Pharmacokinetics of Iptacopan (LNP023) in Participants With Autoimmune Benign Hematological Disorders Immune Thrombocytopenia (ITP), Cold Agglutinin Disease (CAD) Phase 2
  • Country: 
    Germany
  • Country: 
    Korea, Republic of
  • Country: 
    Spain
  • Country: 
A 52 Week, Multi-center, Randomized, Double-blind Placebo-controlled Study to Assess the Clinical Efficacy and Safety of Ligelizumab (QGE031) in Decreasing the Sensitivity to Peanuts in Patients With Peanut Allergy Allergy, Peanut Phase 3
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Canada
  • Country: 
A Randomized, Open-label, Phase I/II Open Platform Study Evaluating Safety and Efficacy of Novel Ruxolitinib Combinations in Myelofibrosis Patients Myelofibrosis Phase 1, Phase 2
  • Country: 
    Australia
  • Country: 
    Austria
  • Country: 
    Belgium
  • Country: 
A Special Drug Use-results Survey to Evaluate the Safety and Efficacy of Subcutaneous Administration of Cosentyx in Pediatric Patients With Psoriasis Vulgaris, Psoriatic Arthritis, or Pustular Psoriasis Psoriasis Vulgaris, Psoriatic Arthritis, Pustular Psoriasis Not Given
  • Country: 
    Japan
A Phase Ib, Multi-arm, Open-label, Study of HDM201 in Combination With MBG453 or Venetoclax in Adult Subjects With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS) Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Phase 1
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Germany
  • Country: 
A Randomized, Subject and Investigator Blinded, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis Atopic Dermatitis Phase 2
  • Country: 
    Spain
Health-related Quality of Life, Symptom Severity, and Pain Among Patients Treated With Alpelisib for PIK3CA-related Overgrowth Spectrum: A Mixed-methods Observational Study PIK3CA-related Overgrowth Spectrum Not Given
  • Country: 
    United States